Galderma Group AG - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
GALDY Over the counter 2840 www.galderma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galderma Group AG

Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile - Nov 4th, 2025 11:00 pm
EQT completes sale of shares in Galderma Group AG - Oct 30th, 2025 10:56 am
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance - Oct 22nd, 2025 11:00 pm
Galderma Group AG's (VTX:GALD) Intrinsic Value Is Potentially 78% Above Its Share Price - Oct 2nd, 2025 7:34 am
AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education - Sep 23rd, 2025 11:00 pm
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay - Sep 17th, 2025 11:00 pm
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin - Sep 16th, 2025 11:00 pm
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch - Sep 10th, 2025 11:00 pm
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market - Sep 9th, 2025 11:00 pm
Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance - Jul 23rd, 2025 11:00 pm
With A 3.0% Return On Equity, Is Galderma Group AG (VTX:GALD) A Quality Stock? - Jul 22nd, 2025 4:39 am
Galderma Unveils Final Nine-Month Data Showing Lasting Efficacy and Patient Satisfaction With Its Injectable Aesthetics Portfolio When Addressing Facial Aesthetic Changes After Medication-Driven Weight Loss - Jul 16th, 2025 11:00 pm
3 European Stock Picks Estimated To Be Trading At Up To 46.8% Discount - Jul 6th, 2025 11:37 pm
European Stocks That May Be Trading Below Estimated Value In July 2025 - Jul 1st, 2025 11:37 pm
Galderma Announces Departure of Its Chief Financial Officer - Jun 30th, 2025 11:00 pm
European Stocks Priced Below Estimated Value In June 2025 - Jun 26th, 2025 4:37 am
European Market: BFF Bank And 2 Other Stocks Trading At Estimated Discounts - Jun 25th, 2025 11:47 pm
European Value Stocks: Assessing 3 Companies Trading Below Estimated Fair Value - Jun 25th, 2025 4:37 am
3 Global Stocks Estimated To Be Up To 47.7% Below Intrinsic Value - Jun 25th, 2025 3:38 am
While individual investors own 28% of Galderma Group AG (VTX:GALD), private equity firms are its largest shareholders with 39% ownership - Jun 24th, 2025 11:40 pm